Porfimer Sodium: Clinical Trials

22 trials of Porfimer Sodium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 5 terminated, 2 unknown, 2 withdrawn. 8 Phase 2, 7 Phase 1, 4 Phase 3, 2 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 6, Terminated 2
Phase 17Completed 5, Terminated 2
Phase 34Completed 2, Unknown 1, Withdrawn 1
Not applicable2Terminated 1, Withdrawn 1
Early Phase 11Unknown 1

Follow Porfimer Sodium: new trials by email Literature Review of Porfimer Sodium trials Research Report on Porfimer Sodium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
Porfimer Sodium, Video-Assisted Thoracic Surgery, Photodynamic Therapy - Lung Non-Small Cell Carcinoma, Pleural Disorder
Phase 1TerminatedRoswell Park Cancer Institute52022-03-102026-02-04
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
Light Dosimetry for Intranoperative Therapy, Photodynamic Therapy, Porfimer Sodium - Malignant Mesothelioma, Non-Small Cell Lung Carcinoma
Phase 1CompletedRoswell Park Cancer Institute92021-09-172026-03-27
Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study
Porfimer sodium, Ethiodized oil, Novel light delivery methods of photodynamic therapy - Non-small Cell Lung Cancer (NSCLC), Lung Metastasis
Early Phase 1UnknownTaoyuan General Hospital32021-03-012021-02-15
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer
Porfimer Sodium, Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy - Locally Advanced Lung Carcinoma, Non-Small Cell Lung Carcinoma
Phase 1 / Phase 2CompletedRoswell Park Cancer Institute192020-02-122026-05-14
Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer
Nivolumab, Porfimer Sodium, Interstitial Illumination Photodynamic Therapy - Recurrent Head and Neck Carcinoma, Locally Advanced Head and Neck Carcinoma
Phase 1TerminatedRoswell Park Cancer Institute52019-07-102025-03-11
Safety of PDT-Photofrin® Prior to Lung Surgery
Porfimer Sodium, Fiber optic - Lung Cancer, Lung Cancer Metastatic
Phase 1CompletedConcordia Laboratories Inc.102017-08-142020-01-13
Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer
Porfimer sodium, Fiber optic - Non-small Cell Lung Cancer (NSCLC), Lung Metastasis
Phase 1CompletedConcordia Laboratories Inc.52017-01-262020-03-04
Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy
porfimer sodium, therapeutic conventional surgery, photodynamic therapy - Stage III Malignant Mesothelioma, Stage IIIB Non-small Cell Lung Cancer
Not applicableWithdrawnOhio State University Comprehensive Cancer Center2014-09-042019-03-21
Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
Laboratory Biomarker Analysis, Photodynamic Therapy, Porfimer Sodium - Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous Carcinoma
Phase 2TerminatedRoswell Park Cancer Institute32014-04-012017-10-11
Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
porfimer sodium, endoscopic ultrasonography, photodynamic therapy - Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas
Phase 1CompletedJohn DeWitt122013-04-192018-12-13
Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease
porfimer sodium, bronchoscopy - Lung Cancer
CompletedOhio State University Comprehensive Cancer Center352008-12-012018-07-05
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery
porfimer sodium, biliary stenting - Extrahepatic Bile Duct Cancer, Gallbladder Cancer
Phase 3CompletedUniversity College, London922007-07-012013-02-20
High Light and Low Light Dose PDT in Glioma
porfimer sodium, adjuvant therapy, conventional surgery - Brain and Central Nervous System Tumors
Phase 3CompletedCase Comprehensive Cancer Center12005-03-012010-06-11
Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
chemotherapy, porfimer sodium, immunohistochemistry staining method - Lung Cancer, Metastatic Cancer
Phase 2TerminatedAbramson Cancer Center at Penn Medicine92004-11-012020-11-24
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
Porfimer Sodium, Photodynamic Therapy - Head and Neck Cancer, Precancerous/Nonmalignant Condition
Phase 2CompletedUniversity of Miami452003-06-012017-02-08
Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat
porfimer sodium, Photdynamic Therapy (PDT) - Head and Neck Cancer
Not applicableTerminatedRoswell Park Cancer Institute302001-10-012014-07-04
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
porfimer sodium - Extrahepatic Bile Duct Cancer, Gallbladder Cancer
Phase 2CompletedMemorial Sloan Kettering Cancer Center41999-03-012013-03-04
Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
adjuvant therapy, conventional surgery, porfimer sodium - Malignant Mesothelioma
Phase 2CompletedRoswell Park Cancer Institute121999-03-012011-03-01
Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
carmustine, lomustine, porfimer sodium - Brain and Central Nervous System Tumors
Phase 3UnknownColorado Health Foundation2701998-04-012013-11-06
Photodynamic Therapy in Treating Patients With Early Esophageal Cancer
porfimer sodium - Esophageal Cancer
Phase 2CompletedRoswell Park Cancer Institute301995-10-012011-12-23

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (8)  ·  Lung Neoplasms (5)  ·  Bile Duct Neoplasms (3)  ·  Gallbladder Neoplasms (3)  ·  Head and Neck Neoplasms (3)  ·  Mesothelioma, Malignant (3)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Astrocytoma (2)  ·  Brain Neoplasms (2)  ·  Central Nervous System Neoplasms (2)  ·  Glioblastoma (2)  ·  Gliosarcoma (2)  ·  Laryngeal Neoplasms (2)  ·  Mouth Neoplasms (2)  ·  Pancreatic Neoplasms (2)

Sponsors

Roswell Park Cancer Institute (9)  ·  Concordia Laboratories Inc. (2)  ·  Ohio State University Comprehensive Cancer Center (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Case Comprehensive Cancer Center (1)  ·  Colorado Health Foundation (1)  ·  John DeWitt (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Taoyuan General Hospital (1)  ·  University College, London (1)  ·  University of Miami (1)

Countries

United States (19)  ·  Canada (3)  ·  United Kingdom (1)

Top investigators

Erin O'Neil (1)  ·  Francisco Civantos, Jr., MD (1)  ·  Fred W. Hetzel, PhD, JD (1)  ·  Hans Gerdes, MD (1)  ·  Hassan Arshad (1)  ·  Hector R. Nava, MD, FACS (1)  ·  James Farrell, MD (1)  ·  John M DeWitt, MD (1)  ·  Keith Cengel, MD, PhD (1)  ·  Kimberly Wooten, MD (1)  ·  Meng Welliver (1)  ·  Michelle Depot, Ph.D. (1)  ·  Nathaniel Ivanick, MD (1)  ·  Nestor R. Rigual, MD (1)  ·  Robert J. Maciunas, MD (1)

Results publications

PMID 14688713, PMID 19687399, PMID 23055220, PMID 29732193, PMID 30222972, PMID 32802440

NIH funding

P01CA055791 (1), P30CA008748 (1), P30CA016056 (1), P30CA043703 (1), R01CA193610 (1), R44CA265656 (1)